Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.67 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19886228 | 1.00 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL5655527 | 1.00 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL16520347 | 0.89 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL18241838 | 0.89 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL18241837 | 0.89 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL13220703 | 0.87 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL159509 | 0.86 | — | — | |
| SCHEMBL2919638 | 0.86 | — | — | |
| SCHEMBL19882494 | 0.84 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL27816090 | 0.83 | ALDH1A1 (0.64) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2480591-B1 | ALKOXYLATED CYCLIC DIAMINES AND USE THEREOF AS EMULSION BREAKERS | CLARIANT FINANCE BV LTD (VG) | 2013-11-06 | — | — | EP | claimed |
| US-20120232171-A1 | Alkoxylated Cyclic Diamines And Use Thereof As Emulsion Breakers | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-09-13 | — | — | US | claimed |
| EP-2480591-A1 | ALKOXYLATED CYCLIC DIAMINES AND USE THEREOF AS EMULSION BREAKERS | Clariant Finance (BV) Limited (VG) | 2012-08-01 | — | — | EP | claimed |
| WO-2011035854-A1 | ALKOXYLATED CYCLIC DIAMINES AND USE THEREOF AS EMULSION BREAKERS | CLARIANT INTERNATIONAL LTD (CH) | 2011-03-31 | — | — | WO | claimed |
| US-10118987-B2 | Hydrocarbon-based polymers bearing dithiocyclocarbonate end groups | BOSTIK SA (FR) | 2018-11-06 | — | — | US | disclosed |
| US-20180051130-A1 | Novel hydrocarbon-based polymers bearing dithiocyclocarbonate end groups | BOSTIK SA (FR) | 2018-02-22 | — | — | US | disclosed |
| US-9403719-B2 | Curable polymer mixtures | BYK-CHEMIE GMBH (DE) | 2016-08-02 | — | — | US | disclosed |
| EP-2480591-B1 | ALKOXYLATED CYCLIC DIAMINES AND USE THEREOF AS EMULSION BREAKERS | CLARIANT FINANCE BV LTD (VG) | 2013-11-06 | — | — | EP | disclosed |
| US-20120232171-A1 | Alkoxylated Cyclic Diamines And Use Thereof As Emulsion Breakers | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-09-13 | — | — | US | disclosed |
| EP-2480591-A1 | ALKOXYLATED CYCLIC DIAMINES AND USE THEREOF AS EMULSION BREAKERS | Clariant Finance (BV) Limited (VG) | 2012-08-01 | — | — | EP | disclosed |
| US-20110190420-A1 | CURABLE POLYMER MIXTURES | BYK-CHEMIE GMBH (DE) | 2011-08-04 | — | — | US | disclosed |
| WO-2011035854-A1 | ALKOXYLATED CYCLIC DIAMINES AND USE THEREOF AS EMULSION BREAKERS | CLARIANT INTERNATIONAL LTD (CH) | 2011-03-31 | — | — | WO | disclosed |
| US-7235593-B2 | Mixing in the absence of actinic radiation a triarylsulfonium, diaryliodonium, dialkylphenacylsulfonium or hydroxyphenyldialkylsulfonium photoinitiator with an oxetane or oxirane monomer/oligomer component and pre-irradiating to activate while controlling temperature to prevent spontaneous polymerization | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235593-B2 | Mixing in the absence of actinic radiation a triarylsulfonium, diaryliodonium, dialkylphenacylsulfonium or hydroxyphenyldialkylsulfonium photoinitiator with an oxetane or oxirane monomer/oligomer component and pre-irradiating to activate while controlling temperature to prevent spontaneous polymerization | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232171-A1 | Alkoxylated Cyclic Diamines And Use Thereof As Emulsion Breakers | AOC1, AOC2, C9 | ALDH1A1 904/4885TSHR 4584/4885MAPK1 3525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.